Literature DB >> 17405982

Pseudo-pseudohypercalcaemia, apparent primary hyperparathyroidism and Waldenström's macroglobulinaemia.

A Elfatih1, N R Anderson, M N Fahie-Wilson, R Gama.   

Abstract

An apparent primary hyperparathyroidism was reported due to pseudo-pseudohypercalcaemia in a 74-year-old man with Waldenström's macroglobulinaemia. It is important to recognise artificially elevated serum calcium levels so as to avoid erroneous diagnosis, unnecessary investigations and potentially inappropriate treatment.

Entities:  

Mesh：

Year:  2007        PMID： 17405982      PMCID： PMC2001100          DOI： 10.1136/jcp.2006.036756

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  5 in total

Review 1.  Waldenström's macroglobulinemia: clinical features, complications, and management.

Authors:  M A Dimopoulos; P Panayiotidis; L A Moulopoulos; P Sfikakis; M Dalakas
Journal:  J Clin Oncol       Date:  2000-01       Impact factor: 44.544

Review 2.  Waldenström's macroglobulinemia.

Authors:  M A Dimopoulos; E Galani; C Matsouka
Journal:  Hematol Oncol Clin North Am       Date:  1999-12       Impact factor: 3.722

Review 3.  Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century.

Authors:  John P Bilezikian; John T Potts; Ghada El-Hajj Fuleihan; Michael Kleerekoper; Robert Neer; Munro Peacock; Jonas Rastad; Shonni J Silverberg; Robert Udelsman; Samuel A Wells
Journal:  J Clin Endocrinol Metab       Date:  2002-12       Impact factor: 5.958

4.  Pseudohypercalcaemia in two patients with IgM paraproteinaemia.

Authors:  R John; D Oleesky; B Issa; M F Scanlon; C P Williams; C B Harrison; D F Child
Journal:  Ann Clin Biochem       Date:  1997-11       Impact factor: 2.057

5.  Hypercalcaemia due to calcium binding IgM paraprotein in Waldenström's macroglobulinaemia.

Authors:  L Side; M N Fahie-Wilson; M J Mills
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.